Grace Therapeutics, Inc. · NASDAQ:GRCE

ADAR1 Capital Management, LLC reported a 9.90% stake in Grace Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

ADAR1 Capital Management, LLC reported a 9.90% stake in Grace Therapeutics, Inc., 1,806,216 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
9.90%
Shares
1,806,216
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
ADAR1 Capital Management, LLC9.90%1,806,216
ADAR1 Capital Management GP, LLC8.60%1,525,757
Daniel Schneeberger9.90%1,806,216

Source

View original at SEC

Related